Effect of a new anti-inflammatory
drug which has a little
ulcer inducing property on gastrointestinal tract,
TA-60 (2-[4-(3-methyl-2-butenyl) phenyl]
propionic acid), on the
prostaglandin (PG) metabolism was investigated.
TA-60 inhibited the
PGE2 biosynthesis of the bovine seminal vesicle microsome dose-dependently. The inhibition constant (Ki) of
TA-60 was approximately 8 microM. The potency of
TA-60 was approximately the same and two times that of
ibuprofen (IP) and
phenylbutazone (PBZ), respectively.
TA-60 did not show the time dependent inhibition of the
PGE2 biosynthesis unlikely to
indomethacin (IM). The decrease in the
PGE2 contents in the stomach of the rats by
TA-60 reached a plateau and the content was not decreased to less than a certain level. The
PGE2 content of the intestine was not changed by
TA-60.
TA-60 did not inhibit the activity of the PG degradating
enzyme, 15-hydroxy PG
dehydrogenase (15-OH-PG-DH) of the gastric mucosa like the other non-steroidal anti-inflammatory drugs (
NSAIDs): IP, PBZ and IM. These results suggest that the slight ulcerating effect of
TA-60 on the gastrointestinal tract might be resulted from the small decreasing effect of
TA-60 on the gastrointestinal level of
PGE2.